Prelude Capital Management, LLC Ark Genomic Revolution ETF (De Transaction History
Prelude Capital Management, LLC
- $1.57 Billion
- Q3 2024
A detailed history of Prelude Capital Management, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Prelude Capital Management, LLC holds 6,600 shares of ARKG stock, worth $168,894. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,600Holding current value
$168,894% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ARKG
# of Institutions
286Shares Held
24.5MCall Options Held
3.02MPut Options Held
2.65M-
Jpmorgan Chase & CO New York, NY2.96MShares$75.6 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.9MShares$74.3 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.43MShares$62.2 Million2.95% of portfolio
-
Goldman Sachs Group Inc New York, NY1.81MShares$46.4 Million0.01% of portfolio
-
Citigroup Inc1.68MShares$43 Million0.03% of portfolio